Bank of America Corp DE cut its stake in Rapport Therapeutics (NASDAQ:RAPP – Free Report) by 65.6% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 6,578 shares of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback